ImageneBio, Inc. Restricted Cash
ImageneBio, Inc. (IMA) had Restricted Cash of $900.00 thousand as of 2025-06-30, per its 10-Q filed 2025-07-24.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2025-07-24
- 2025-06-30: Restricted Cash $900.00K.
- 2025-03-31: Restricted Cash $900.00K.
- 2024-12-31: Restricted Cash $900.00K.
- 2024-09-30: Restricted Cash $900.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-06-30 | $900.00K 10-Q · filed 2025-07-24 |
| 2025-03-31 | $900.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $900.00K 10-Q · filed 2025-07-24 |
| 2024-09-30 | $900.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.30M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-06 |
| 2022-12-31 | $900.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $900.00K 10-K · filed 2023-03-14 |
| 2020-12-31 | $900.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |